Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine

被引:18
|
作者
Wu, Fan [1 ]
Yuan, Xiao-Yi [1 ]
Huang, Wei-Shan [1 ]
Chen, Ying-Hua [1 ]
机构
[1] Tsinghua Univ, Immunol Lab, Dept Biol, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China
关键词
Influenza virus; Combined vaccination; M2e; Split influenza vaccine; Heterosubtypic protection; PANDEMIC CONTROL STRATEGIES; EXTRACELLULAR DOMAIN; AVIAN INFLUENZA; A H5N1; VIRUS; IMMUNITY; PROTEIN; MICE; INFECTION;
D O I
10.1016/j.vaccine.2008.11.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is urgent need to develop influenza vaccines with broad-spectrum protection against the potential influenza pandemic. The extracellular domain of influenza M2 protein (M2e) is considered as an appropriate target to induce heterosubtypic protection. We investigated the immunity and protection induced by combined vaccination with synthetic M2e peptide and traditional split influenza vaccine. The combined vaccination was able to induce similar strain-specific hemagglutinin inhibition (HI) antibodies as vaccination of split virus alone. However, aluminum-adjuvant but not oil-in-water-emulsion adjuvant combined vaccination was able to induce high titers of anti-M2e antibodies and provoke M2e-specific T lymphocyte response. Furthermore, we found that the addition of M2e peptide greatly enhanced the cross-protective efficacy of split virus in aluminum adjuvant but slightly weakened the efficacy of vaccination in oil-in-water-emulsion adjuvant. Moreover, aluminum-adjuvant combined vaccination conferred complete cross-protection against heterosubtypic influenza virus. According to the results, we suggest that the M2e peptide should be added into split influenza vaccine in the preparation for the potential influenza pandemic. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6095 / 6101
页数:7
相关论文
共 50 条
  • [31] Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza a virus in mice
    Kim, Eun-Ha
    Lee, Jun-Han
    Pascua, Philippe Noriel Q.
    Song, Min-Suk
    Baek, Yun-Hee
    Kwon, Hyeok-il
    Park, Su-Jin
    Lim, Gyo-Jin
    Decano, Arun
    Chowdhury, Mohammed Y. E.
    Seo, Su-Kyung
    Song, Man Ki
    Kim, Chul-Joong
    Choi, Young-Ki
    VIROLOGY JOURNAL, 2013, 10
  • [32] Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin
    Stepanova, Liudmila A.
    Kotlyarov, Roman Y.
    Kovaleva, Anna A.
    Potapchuk, Marina V.
    Korotkov, Alexandr V.
    Sergeeva, Mariia V.
    Kasianenko, Marina A.
    Kuprianov, Victor V.
    Ravin, Nikolai V.
    Tsybalova, Liudmila M.
    Skryabin, Konstantin G.
    Kiselev, Oleg I.
    PLOS ONE, 2015, 10 (03):
  • [33] Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection
    Watkins, Hannah C.
    Rappazzo, C. Garrett
    Higgins, Jaclyn S.
    Sun, Xiangjie
    Brock, Nicole
    Chau, Annie
    Misra, Aditya
    Cannizzo, Joseph P. B.
    King, Michael R.
    Maines, Taronna R.
    Leifer, Cynthia A.
    Whittaker, Gary R.
    DeLisa, Matthew P.
    Putnam, David
    MOLECULAR THERAPY, 2017, 25 (04) : 989 - 1002
  • [34] HBc particles carrying multiple copies of influenza M2e peptides into the major immunodominant region as a candidate influenza vaccine
    Blokhina, Elena
    Kuprianov, Victor
    Ravin, Nikolai
    JOURNAL OF BIOTECHNOLOGY, 2014, 185 : S103 - S103
  • [35] Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection
    Kim, Min-Chul
    Lee, Jeong Woo
    Choi, Hyo-Jick
    Lee, Yu-Na
    Hwang, Hye Suk
    Lee, Jongsang
    Kim, Cheol
    Lee, Jong Seok
    Montemagno, Carlo
    Prausnitz, Mark R.
    Kang, Sang-Moo
    JOURNAL OF CONTROLLED RELEASE, 2015, 210 : 208 - 216
  • [36] Evaluation of an inactivated Salmonella-recombinant vaccine expressing type A influenza M2e epitopes.
    Gaona-Ramirez, G.
    Layton, S. L.
    Wolfenden, A. D.
    Wolfenden, R. E.
    Pumford, N. R.
    Tellez, G.
    Hargis, B. M.
    POULTRY SCIENCE, 2008, 87 : 80 - 81
  • [37] Development of live attenuated Bordetella pertussis strains expressing the universal influenza vaccine candidate M2e
    Li, Rui
    Lim, Annabelle
    Ow, Stephanie T. L.
    Phoon, Meng Chee
    Locht, Camille
    Chow, Vincent T.
    Alonso, Sylvie
    VACCINE, 2011, 29 (33) : 5502 - 5511
  • [38] Delivery of gold nanoparticle-conjugated M2e influenza vaccine in mice using coated microneedles
    Nesovic, Lazar D. D.
    Roach, Carsen J. J.
    Joshi, Gaurav
    Gill, Harvinder Singh
    BIOMATERIALS SCIENCE, 2023, 11 (17) : 5859 - 5871
  • [39] A Universal Influenza Vaccine Using an M2e/NP Fusion Protein Linked to Immunostimulatory Sequences (ISS)
    Higgins, D.
    dela Cruz, T.
    Milley, R.
    Hillebrand, A.
    Amuel, C.
    Van Nest, G.
    VACCINE, 2008,
  • [40] The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine
    Wu, Fan
    Yuan, Xiao-Yi
    Li, Jing
    Chen, Ying-Hua
    VACCINE, 2009, 27 (32) : 4320 - 4324